Sygnis Bioscience GmbH & Co. KG
Records under this name other than patents Sygnis Bioscience GmbH & Co. KG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Sygnis Bioscience GmbH & Co. KG
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,349,619 | Method for detecting and analyzing protein interactions in-vivo Term ended Term ended May 4, 2024 · USPTO record | Term ended | Term ended May 4, 2024 | USPTO record |
| US 7,785,601 | Methods of treating neurological conditions with hematopoietic growth factors Formerly held Lapsed on the fee record Ended Aug 31, 2022 · USPTO record | Lapsed on the fee record | Ended Aug 31, 2022 | USPTO record |
| US 8,071,543 | Methods of treating neurological conditions with hematopoeitic growth factors Formerly held Lapsed on the fee record Ended Dec 6, 2019 · USPTO record | Lapsed on the fee record | Ended Dec 6, 2019 | USPTO record |
| US 8,053,407 | Methods of treating neurological conditions with hematopoeitic growth factors Formerly held Lapsed on the fee record Ended Nov 8, 2019 · USPTO record | Lapsed on the fee record | Ended Nov 8, 2019 | USPTO record |
| US 7,884,069 | Methods of treating neurological conditions with hematopoeitic growth factors Formerly held Lapsed on the fee record Ended Feb 8, 2019 · USPTO record | Lapsed on the fee record | Ended Feb 8, 2019 | USPTO record |
| US 7,695,723 | Methods of treating neurological conditions with hematopoietic growth factors Formerly held Lapsed on the fee record Ended Apr 13, 2018 · USPTO record | Lapsed on the fee record | Ended Apr 13, 2018 | USPTO record |
| US 7,585,635 | Method for detecting and analyzing protein interactions in vivo Lapsed on the fee record Ended Sep 8, 2017 · USPTO record | Lapsed on the fee record | Ended Sep 8, 2017 | USPTO record |
| US 7,361,502 | Nucleic acid molecule encoding a neuronal serine-threonine protein kinase Lapsed on the fee record Ended Apr 22, 2016 · USPTO record | Lapsed on the fee record | Ended Apr 22, 2016 | USPTO record |
| US 7,361,681 | Method of treating amytrophic lateral sclerosis using melatonin Lapsed on the fee record Ended Apr 22, 2016 · USPTO record | Lapsed on the fee record | Ended Apr 22, 2016 | USPTO record |
| US 7,575,857 | Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders Lapsed on the fee record Ended Aug 18, 2013 · USPTO record | Lapsed on the fee record | Ended Aug 18, 2013 | USPTO record |